Skip to main content
64°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gossamer Bio Inc
(NQ:
GOSS
)
0.6421
+0.0021 (+0.33%)
Streaming Delayed Price
Updated: 11:25 AM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gossamer Bio Inc
< Previous
1
2
3
4
5
Next >
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
Barclays Downgrades Gossamer Bio: Here's What You Need To Know
December 07, 2022
Via
Benzinga
What 9 Analyst Ratings Have To Say About Gossamer Bio
December 07, 2022
Via
Benzinga
ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday
December 07, 2022
Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Gossamer Bio
November 17, 2022
Via
Benzinga
Analyst Ratings for Gossamer Bio
November 17, 2022
Via
Benzinga
4 Analysts Have This to Say About Gossamer Bio
November 17, 2022
Via
Benzinga
Dow Dips Over 500 Points; Nasdaq Down 2.5%
December 06, 2022
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 2.5% on Tuesday.
Via
Benzinga
Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
December 06, 2022
Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...
Via
Benzinga
Analyst Turns Bullish On Aerovate As Competitor Data Reinforce Lead Program Thesis
December 06, 2022
Via
Benzinga
What 5 Analyst Ratings Have To Say About Gossamer Bio
October 20, 2022
Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:
Via
Benzinga
What 4 Analyst Ratings Have To Say About Gossamer Bio
September 19, 2022
Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:
Via
Benzinga
Where Gossamer Bio Stands With Analysts
September 19, 2022
Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 06, 2022
Via
Benzinga
Souring Sentiment On Wall Street Sends Dow Down Triple Digits
December 06, 2022
Doubts over the Fed's next move are being compounded with renewed recession anxieties, and this sour sentiment is weighing on markets this afternoon.
Via
Talk Markets
S&P 500 Down Over 1%; Crude Oil Falls Sharply
December 06, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 250 points on Tuesday.
Via
Benzinga
President Biden Is Bringing Taiwan Semi (TSM) Stock a HUGE Catalyst
December 06, 2022
Taiwan Semiconductor (TSM) stock is on the move Tuesday as investors prepare for President Joe Biden to visit the company's Arizona plant.
Via
InvestorPlace
Meta Platforms, Herbalife And Some Other Big Stocks Moving Lower On Tuesday
December 06, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Is Gossamer Bio (GOSS) Stock Down Over 70% Today?
December 06, 2022
GOSS stock is plunging over 70%. The company's hypertension drug reportedly failed to perform better than a competing treatment.
Via
InvestorPlace
Dow Drops 100 Points; US Trade Deficit Widens In October
December 06, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.
Via
Benzinga
Gossamer Bio Shares Plummet As Hypertension Trial Fall Short Of Expectation
December 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 06, 2022
Via
Benzinga
Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH
December 06, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
November 30, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial
November 17, 2022
Via
Benzinga
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Gossamer Bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
October 20, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
September 21, 2022
Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022
September 19, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.